In virtuous cycle, foundation uses drug royalty riches to back new cystic fibrosis drug research in Bay Area

The Cystic Fibrosis Foundation is spinning some of the half-billion dollars it received as part of a royalty deal in 2016 into Bay Area companies looking at ways to tackle persistent infections and perhaps even mutation-fixing cures.